Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
TNF inhibitor
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:code |
L04 A B04
|
| gptkbp:effective_date |
2008-04-22
|
| gptkbp:formulation |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cimzia
|
| gptkbp:ingredients |
gptkb:certolizumab_pegol
|
| gptkbp:is_used_for |
treatment of ankylosing spondylitis
treatment of psoriatic arthritis treatment of rheumatoid arthritis treatment of Crohn's disease |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:manager |
subcutaneous injection
|
| gptkbp:manufacturer |
UCBS. A.
|
| gptkbp:side_effect |
fatigue
headache nausea increased risk of infections injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:bfsParent |
gptkb:Abbott
|
| gptkbp:bfsLayer |
4
|